Company Overview - C4 Therapeutics, Inc. (C4T) is a clinical-stage biopharmaceutical company focused on advancing targeted protein degradation (TPD) science to create innovative medicines that can transform patients' lives [3] - The company is developing targeted oncology programs through clinical studies and utilizes its TORPEDO platform to design and optimize small-molecule medicines for challenging diseases [3] - C4T's degrader medicines aim to leverage the body's natural protein recycling system to degrade disease-causing proteins, potentially addressing drug resistance and improving patient outcomes [3] Upcoming Events - C4T management will participate in the Barclays 28 Annual Global Healthcare Conference on March 10, 2026, at 8:00 AM ET in Miami, Florida, featuring a fireside chat [2] - The company will also present at the TD Cowen 46 Annual Healthcare Conference on March 3, 2026, at 11:50 AM ET in Boston, Massachusetts, where management will engage in a fireside chat [4]

Core Insights - C4 Therapeutics, Inc. (C4T) is participating in the Guggenheim Emerging Outlook: Biotech Summit 2026, scheduled for February 11-12, 2026, in New York, NY [1] - The company focuses on advancing targeted protein degradation (TPD) science to develop innovative medicines that can transform patient lives [3] Event Details - The fireside chat will take place on February 11, 2026, at 11:30 AM ET, with a live webcast available on the company's website [2] - An archived replay of the webcast will be accessible for approximately 90 days following the event [2] Company Overview - C4 Therapeutics is a clinical-stage biopharmaceutical company that aims to create a new generation of medicines through targeted protein degradation [3] - The company is advancing targeted oncology programs and utilizing its TORPEDO platform to design and optimize small-molecule medicines for challenging diseases [3] - C4T's degrader medicines are intended to leverage the body's natural protein recycling system to degrade disease-causing proteins, potentially addressing drug resistance and improving patient outcomes [3]

Core Insights - C4 Therapeutics, Inc. is participating in the 8th Annual Evercore Healthcare Conference from December 2-4, 2025, indicating its active engagement in the healthcare investment community [1][2] - The company focuses on advancing targeted protein degradation science to develop innovative medicines aimed at transforming patient outcomes [3] Company Overview - C4 Therapeutics is a clinical-stage biopharmaceutical company listed on Nasdaq under the ticker CCCC [3] - The company is dedicated to creating a new generation of medicines through targeted protein degradation, which aims to address difficult-to-treat diseases [3] - C4T utilizes its TORPEDO platform to design and optimize small-molecule medicines, enhancing the potential to overcome drug resistance and improve patient outcomes [3] Event Details - The fireside chat will take place on December 3, 2025, at 3:25 pm ET, with a live webcast available on the company's website [2] - An archived replay of the webcast will be accessible for approximately 90 days following the live event [2]